MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-CH-01-0001508
Sanctus Global Formulations Limited - pharma in Chandigarh, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹47.05 Cr
▲ 32% YoY
Net profit · FY 2025
₹28.5 Lakh
Net margin 0.6%
EBITDA · FY 2025
₹2.13 Cr
EBITDA margin 4.5%
Authorised capital
₹4.5 Cr
Registered with MCA
Paid-up capital
₹4.16 Cr
Issued & subscribed
Open charges
₹26.87 Cr
Satisfied ₹34.67 Cr
Company age
26 yrs
Est. 2000
Employees · EPFO
108
Provident fund records
About Sanctus Global Formulations Limited
Data last updated:
Sanctus Global Formulations Limited is a public limited company based in Chandigarh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 21 November 2000 and has been in existence for over 26 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U29297CH2000PLC041530. Its GSTIN is 04AABCC9421B1ZA (Chandigarh). The company holds 4 GST registrations, of which 3 are active.
The company has an authorised share capital of ₹4.5 Cr and a paid-up capital of ₹4.16 Cr. It was formerly known as Crescent Therapeutics Limited and Crescent Therapeutics Private Limited. It is led by directors including Vijay Kumar Joshi and Sahil Joshi.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at SCO – 56 – 57 (3rd Floor) Sector 17 – D, Chandigarh, India – 160017.
As per the financials filed for FY 2025, the company reported a revenue of ₹47.05 Cr, a growth of 32% compared to the previous year. For the same year it recorded a net profit of ₹28.5 Lakh (net margin 0.6%) and EBITDA of ₹2.13 Cr (EBITDA margin 4.5%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years and 10% over five years.
The company has about 108 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Sanctus Global. As per MCA filings, the company has open charges of ₹26.87 Cr and satisfied charges of ₹34.67 Cr on record. Court records list 36 cases involving the company, including 22 filed by the company and 14 filed against it; 14 cases are pending.
Sanctus Global Formulations Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-CH-01-0001508). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website sanctusglobal.com.
Company details
CIN U29297CH2000PLC041530
Registration Number 041530
Incorporation Date 21 November 2000
ROC Chandigarh
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-CH-01-0001508
Name history
Sanctus Global Formulations has undergone 2 name changes throughout its history. The company was previously known as Crescent Therapeutics Limited, and Crescent Therapeutics Private Limited. The current legal name is Sanctus Global Formulations Limited.
| Company Name | Status |
|---|---|
| Sanctus Global Formulations Limited | Current |
| Crescent Therapeutics Limited | Previous |
| Crescent Therapeutics Private Limited | Previous |
CIN history
Sanctus Global Formulations has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U29297CH2000PLC041530, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U29297CH2000PLC041530 | Current |
| U29297TG2000PLC035708 | Previous |
| U29297AP2000PLC035708 | Previous |
Recognitions & Rankings of Sanctus Global Formulations
Contact details
Sanctus Global Formulations Limited's registered office is in Chandigarh, Chandigarh. Its website is sanctusglobal.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressSCO – 56 – 57 (3rd Floor) Sector 17 – D, Chandigarh, India – 160017
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Sanctus Global Formulations Limited, buy the company report.
Comprehensive company report
Sanctus Global Formulations Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Sanctus Global Formulations operates one associated brand: Sanctus Global. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Various pharmaceutical products including tablets, capsules, and nutraceuticals are manufactured. | sanctusglobal.com |
Business activity
The main business activity of Sanctus Global Formulations is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Sanctus Global Formulations Limited, buy the company report.
Financials of Sanctus Global Formulations Limited
FY 2024 filings availableSanctus Global Formulations Limited reported revenue of ₹47.05 Cr (up 32% YoY) for FY 2025.
Revenue · FY 2025
₹47.05 Cr ▲ 32%
Net profit · FY 2025
₹28.5 Lakh margin 0.6%
EBITDA · FY 2025
₹2.13 Cr margin 4.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 32%
3 years · compounded
▲ 7%
5 years · compounded
▲ 10%
EBITDA CAGR growth
1 year
▲ 37%
3 years · compounded
▲ 7%
5 years · compounded
▲ 4%
Revenue has grown at a compounded annual rate (CAGR) of 10% over five years, including 32% growth in the latest year. EBITDA rose 37% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.13 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹28.5 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.5% | ||||
| Net Profit Margin | 0.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sanctus Global Formulations Limited, buy the company report.
Board of directors of Sanctus Global Formulations Limited
Sanctus Global Formulations has 3 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vijay Kumar Joshi | Director | 01 Oct 2016 | 10 Years 0 Months | Current |
| Sahil Joshi Also directs: Sanctus Global Lifesciences Private Limited | Director | 02 Dec 2016 | 9 Years 10 Months | Current |
| Sangeeta Joshi | Director | 06 Jan 2023 | 3 Years 9 Months | Current |
Peer comparison
Sanctus Global Formulations Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Mendine Pharmaceuticals Pvt Ltd | ₹47.44 Cr (FY 2025) | 3.0% | Kolkata, West Bengal, India | |||
| Linux Life Sciences Private Limited | ₹47.4 Cr (FY 2025) | 52.0% | Puducherry, India | |||
| Lozen Pharma Private Limited | ₹47.38 Cr (FY 2025) | 0.0% | Savanur, Karnataka, India | |||
| Sanctus Global Formulations Limitedthis company | ₹47.05 Cr (FY 2025) | ₹28.5 Lakh | 0.6% | 32.0% | 108 | Chandigarh, India |
| Navyug Pharma- Chem Pvt. Ltd. | ₹47.02 Cr (FY 2024) | -13.0% | Gujarat, India | |||
| Quantime World Private Limited | ₹47.01 Cr (FY 2025) | 79.0% | Pune, Maharashtra, India | |||
| Reliance Formulation Pvt Ltd | ₹46.68 Cr (FY 2023) | 4.0% | Ahmedabad, Gujarat, India | |||
| Abhideep Chemicals Pvt Ltd | ₹46.53 Cr (FY 2024) | 9.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Sanctus Global Formulations Limited, buy the company report.
Auditor
Sanctus Global Formulations Limited is audited by ASHWANI K GUPTA & ASSOCIATES for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ASHWANI K GUPTA & ASSOCIATES | FY 2024 | 003803N |
Shareholding
The shareholding of Sanctus Global Formulations Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Sanctus Global Formulations Limited, buy the company report.
Charges & borrowings
Open charges
₹26.87 Cr
Satisfied charges
₹34.67 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 11 Nov 2025 | 101193796 | Others | ₹7.4 Cr | Open | |
| 22 Jul 2025 | 101132330 | Others | ₹1 Cr | Open | |
| 12 Jun 2025 | 101148849 | Others | ₹39 Lakh | Open | |
| 01 Jan 2024 | 100848324 | Others | ₹3 Cr | Open | |
| 23 Nov 2022 | 100661370 | Others | ₹1.25 Cr | Open |
To see the full charge records of Sanctus Global Formulations Limited, buy the company report.
Total charge records: 24 View all charges
Legal cases
Sanctus Global Formulations Limited has 36 court cases on record: 22 filed by Sanctus Global Formulations, 14 filed against it. 14 cases are pending and 22 are disposed.
Total cases
36
Filed by the company
22
Filed against the company
14
Pending
14
Disposed
22
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 28 | 13 | 12 |
| High courts | 8 | 1 | 2 |
Cases on record (5 of 36)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Chandigarh | Cheque dishonour complaint | Filed against the company by Lancer Pharmaceuticals P Ltd. | Disposed |
| District court, Mumbai CMM Courts, Maharashtra | Civil suit | Filed against the company by Ms. Aarti Drugs Ltd., Th Mr. Kiran Liladhar Patel | Disposed |
| District court, Mumbai CMM Courts, Maharashtra | Civil suit | Filed against the company by Ms. Minerva Biogenix Pvt. Ltd. Th Mr. Hiten Sanghavi | Disposed |
| District court, Solan, Himachal Pradesh | Civil suit | Filed against the company by Ms 21St Century Enviro Engineers Private Limited | Disposed |
| District court, Khammam, Telangana | Criminal complaint | Filed against the company by The State of Telangana Represented by Drugs Inspector Khammam Rural | Pending |
To see the full case history of Sanctus Global Formulations Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Sanctus Global Formulations Limited was last rated by Care on 18 May 2026.
| Rating agency | Rated on | Rating |
|---|---|---|
| Care | 18 May 2026 |
To see the full credit ratings and regulatory alerts of Sanctus Global Formulations Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sanctus Global Formulations Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Sanctus Global Formulations Limited has a workforce of 108 employees on its EPFO records as of Apr 04, 2024, across 1 active EPFO establishment.
Employee count
108
Active EPFO establishments
1
Employee growth
6.93%
GST
Sanctus Global Formulations has 4 GST registrations: 3 active and 1 cancelled or inactive.
Total GSTINs
4
Active
3
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 04AABCC9421B1ZA | Chandigarh | Active | 11 Jul 2017 |
| 04AABCC9421B2Z9 | Chandigarh | Active | 19 Sep 2019 |
| 02AABCC9421B1ZE | Himachal Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Sanctus Global Formulations Limited, buy the company report.
Recent activity
Sanctus Global Formulations Limited has 12 board changes on record since 2010: 3 appointments and 9 cessations. The latest: Sangeeta Joshi ceased to be Additional Director on 29 Sep 2023.
Charges
A charge with Others amounted to Rs. 7.40 Cr with Charge ID 101193796 was registered on 11 Nov 2025.
Charges
A charge with Others amounted to Rs. 1.00 Cr with Charge ID 101132330 was registered on 22 Jul 2025.
Charges
A charge with Others amounted to Rs. 0.39 Cr with Charge ID 101148849 was registered on 12 Jun 2025.
AGM
Sanctus Global Formulations Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Sanctus Global Formulations Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chandigarh.
Charges
A charge with Others amounted to Rs. 3.00 Cr with Charge ID 100848324 was registered on 01 Jan 2024.
Ceased
Sangeeta Joshi ceased to be Additional Director.
Appointed
Sangeeta Joshi was appointed as Director.
Charges
A charge with Others amounted to Rs. 1.25 Cr with Charge ID 100661370 was registered on 23 Nov 2022.
Charges
A charge registered on 31 Oct 2017 via Charge ID 100146909 with Others was fully satisfied on 22 Mar 2022.
Charges
A charge with Others of Rs. 9.75 Cr registered on 02 Sep 2014 with Charge ID 10527569 was modified on 02 Feb 2022.
Charges
A charge with Others amounted to Rs. 0.99 Cr with Charge ID 100508432 was registered on 12 Nov 2021.
44 earlier events are in the company report.
Frequently asked questions
Sanctus Global Formulations is an active public limited company based in Chandigarh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 21 November 2000 (26+ years old) and is registered under CIN U29297CH2000PLC041530.
Sanctus Global Formulations has 3 current directors:
- Vijay Kumar Joshi - Director
- Sahil Joshi - Director
- Sangeeta Joshi - Director
The latest financial statements of Sanctus Global Formulations on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Sanctus Global Formulations is 04AABCC9421B1ZA, registered in Chandigarh. The company has 4 GST registrations in all, of which 3 are active and 1 is cancelled or inactive. Other active GSTINs include 04AABCC9421B2Z9 (Chandigarh), 02AABCC9421B1ZE (Himachal Pradesh).
The CIN (Corporate Identification Number) of Sanctus Global Formulations is U29297CH2000PLC041530. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sanctus Global Formulations has 36 court cases on record: 22 filed by the company and 14 filed against it. 14 are pending. Most are in the district courts.
Sanctus Global Formulations was incorporated on 21 November 2000, making it 26+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Sanctus Global Formulations by revenue are Mendine Pharmaceuticals Pvt Ltd, Linux Life Sciences Private Limited, Lozen Pharma Private Limited, Navyug Pharma- Chem Pvt. Ltd, Quantime World Private Limited and 2 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Sangeeta Joshi ceased to be Additional Director on 29 Sep 2023. Sangeeta Joshi was appointed as Director on 06 Jan 2023. Vijay Kumar Joshi ceased to be Additional Director on 30 Sep 2017. Sanctus Global Formulations has 12 board changes on record in total.
Yes, Sanctus Global Formulations is registered as a small enterprise under Udyam registration (number: UDYAM-CH-01-0001508).
Sanctus Global Formulations can be reached through the website sanctusglobal.com. Its registered office is in Chandigarh, India.